TCI Wealth Advisors, Inc. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 185 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$20,316
-1.3%
308
-22.6%
0.00%0.0%
Q4 2022$20,581
-2.0%
398
+29.2%
0.00%0.0%
Q3 2022$21,000
+50.0%
3080.0%0.00%
+50.0%
Q2 2022$14,000
-12.5%
3080.0%0.00%0.0%
Q1 2022$16,000
+6.7%
3080.0%0.00%0.0%
Q4 2021$15,000
+114.3%
308
+175.0%
0.00%
+100.0%
Q2 2021$7,000
+133.3%
112
+55.6%
0.00%0.0%
Q1 2021$3,000720.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders